4144 On Other Exchanges
Symbol
Exchange
4144 is not on other exchanges.

Executive Profile*

William Robert Keller

AgeTotal Calculated CompensationThis person is connected to 52 board members in 7 different organizations across 10 different industries.

See Board Relationships
69--

Background*

Mr. William Robert Keller served as General Manager of Roche (china) Co., Ltd. and Shanghai Roche Pharmaceutical Ltd. from 1994 to 2003. From 1974 to 2003, Mr. Keller served in various positions at Roche Group in South America and Asia. He served as a Senior Consultant to the Shanghai Foreign Investment Development Board from 2003 to 2014. From 2003 to 2014, he served as Deputy General Manager of Shanghai Zhangjiang Biotech and Pharmaceutical Base Development Co., Ltd. ...

Read Full Background

\

Corporate Headquarters*

Zhangjiang High Technology Park
Shanghai, -- --

China

Phone: 86 21 5468 1666
Fax: 86 21 6418 5699

Board Members Memberships*

Director
2008-Present
Independent Director
2010-Present
Chairman
2014-Present
Independent Director
2017-Present
Independent Non-Executive Director

Education*

BS 1972
Zurich University of Applied Sciences Winterthur

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Omar S. Ishrak Chairman & CEO
Medtronic plc
$1.5M
Kevin A. Lobo Chairman and Chief Executive Officer
Stryker Corporation
$1.1M
Alex Gorsky Chairman & CEO
Johnson & Johnson
$1.6M
Emma Walmsley CEO & Director
GlaxoSmithKline plc
--
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact COLAND HOLDINGS LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.